Wednesday, June 10, 2026

Patent intelligence · BR

BR PI0614453

método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante

granted A61K 35/ 32 A IA61K 35/ 36 A IA61K/31409A61K/31555
Status granted
Linked drugs 1
Pipeline programs 1
Years to expiry 6
Applicant portfolio 25
Patent details — BR PI0614453
Jurisdiction
BR
Status
granted
Grant date
Dec 11, 2012
Expiration
Dec 6, 2032
CPC classes
A61K 35/ 32 A I, A61K 35/ 36 A I, A61K/31409, A61K/31555
View on Google Patents ↗

Quick answer

BR PI0614453 (método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante) is held by CERAMOPTEC IND INC [US]. Status: granted. Granted Dec 11, 2012. Expires Dec 6, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
CPC classes
A61K 35/ 32 A I, A61K 35/ 36 A I, A61K/31409, A61K/31555, A61K/8494, A61K/9127

More from CERAMOPTEC IND INC [US]

Related pharmaceutical patents in our USPTO index.

  1. BR PI0714667

    conjugado molecular e respectivo uso

    CERAMOPTEC IND INC [US] · Expires Aug 1, 2033

    granted
  2. MX 2013000877

    APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.

    BIOLITEC PHARMA MARKETING LTD [MY] · Expires Jun 28, 2033

    granted
  3. US 2013041307

    APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT

    CERAMOPTEC IND INC [DE] · Expires Feb 9, 2033

    granted
  4. WO 2013015774

    DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE

    BIOLITEC PHARMA MARKETING LTD [MY] · Expires Jan 26, 2033

    granted
  5. US 2012263625

    GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY

    AICHER DANIEL [DE] · Expires Oct 13, 2032

    granted
  6. US 2012259187

    DYNAMIC COLORECTAL PDT APPLICATION

    KRUIJT BASTIAAN [NL] · Expires Oct 6, 2032

    granted
  7. US 2011206613

    METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT

    WIEHE ARNO [DE] · Expires Aug 20, 2031

    granted

Frequently asked questions

What is US patent PI0614453?

BR PI0614453 (método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante) is held by CERAMOPTEC IND INC [US]. Status: granted. Granted Dec 11, 2012. Expires Dec 6, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.

Who owns BR PI0614453?

CERAMOPTEC IND INC [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.

When does BR PI0614453 expire?

Our index shows an expiration date of Dec 6, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.